News and Resources
More than information - Insights that Inspire Action.



News

December 2, 2025

Fuse® Second Generation Full Spectrum Endoscopy® System Released by EndoChoice®

Read the Full Story

REACH Health Telestroke Solution Increases Use of Lifesaving Stroke Medication

Read the Full Story

John Baackes Selected to Take Helm at L.A. Care Health Plan

Read the Full Story

EndoChoice® Announces Closing of Its Initial Public Offering

Read the Full Story

EndoChoice® Announces $57 Million Raised in Equity Financing

Read the Full Story

December 1, 2025

Nashville Health Care Council Celebrates Commencement of 2015 Fellows Class

Read the Full Story

Schatzlein named CEO of Ascension’s St. Vincent’s HealthCare

Read the Full Story

Community Health Systems Announces Plans to Spin off 38 Hospitals and Quorum Health Resources with revenue of $2.1 billion

Read the Full Story

Taylor Weis Joins Council Capital Investment Team

Read the Full Story





Honors & Awards​

Disclaimer

The endorsements of current or past portfolio company executives are provided as illustrative examples and designed to demonstrate the benefits to portfolio companies of partnering with us. These statements are primarily aimed at prospective portfolio companies and not intended to solicit investors. The portfolio companies covered in these endorsements do not represent all portfolio company investments we have made. The experiences highlighted in these testimonials are solely those of the executives profiled and may not necessarily represent or be indicative of the current, past or future experiences of other portfolio companies. Past results and experiences discussed are not indicative, or a guarantee of future results and experiences. We have not provided cash or other type of compensation in exchange for receiving these endorsements. We do not believe there are typically any material conflicts associated with providing these endorsements. The compensation of our portfolio company executives is primarily driven by the performance of their respective portfolio companies and any discretion we exercise in such compensation determinations is not influenced by whether an executive has provided a favorable statement. Additionally, the economic interests of our portfolio companies’ executives are generally well-aligned with ours and those of our investors. Nevertheless, the fact that these endorsements have been provided by individuals whose compensation we exercise a certain level of control over may incentivize them to provide favorable evaluations of their experiences working with us.